Stockreport

Nano-X Imaging Showcases FDA-Cleared ARC X Rollout, Europe Commercialization Plans at Investor Conference [Yahoo! Finance]

NANO-X IMAGING LTD - Ordinary Shares  (NNOX) 
PDF a recent “tomo 2D” clearance, plus CE approval in early 2025—and says U.S. commercialization began in 2023 with European commercialization planned for 2025 and distribut [Read more]